Alnylam stockholders re-elect three Class III directors at 2022 annual meeting

ALNYLAM PHARMACEUTICALS, INC.

Margaret A. Hamburg, Colleen F. Reitan, Amy W. Schulman re-elected as Class III directors.
Stockholders approved amendment to 2018 Stock Incentive Plan with 93.4M for, 12.4M against.
Non-binding advisory vote on executive compensation passed with 95.3M for, 10.5M against.
PricewaterhouseCoopers ratified as independent auditor for FY 2022 with 109.7M for, 0.6M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.